Response to Mindfulness-Based Cognitive Therapy Differs Between Chronic and Episodic Migraine

Conclusions MBCT-M is a promising treatment for reducing headache-related disability, with greater benefits in episodic than CM. Trial Registration Information ClinicalTrials.gov Identifier: NCT02443519. Classification of Evidence This study provides Class III evidence that MBCT-M reduces headache disability to a greater extent in people with episodic than CM.

http://cp.neurology.org/cgi/content/short/11/3/194?rss=1

Source: Neurology Clinical Practice - June 7, 2021 Category: Neurology Authors: Seng, E. K., Conway, A. B., Grinberg, A. S., Patel, Z. S., Marzouk, M., Rosenberg, L., Metts, C., Day, M. A., Minen, M. T., Buse, D. C., Lipton, R. B. Tags: Migraine, All Neuropsychology/Behavior, Clinical trials Randomized controlled (CONSORT agreement) Research Source Type: research